Journal of Epidemiology and Global Health

Volume 7, Issue 3, September 2017, Pages 155 - 159

Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran

Authors
Akbar Mirsalehiana, Davood Kalantar-Neyestanakib, Morovat Taherikalanic, Fereshteh Jabalamelia, Mohammad Emaneinia, *, emaneini@tums.ac.ir
aDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
bStudent Research Committee, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
cDepartment of Microbiology, School of Medicine, Lorestan University of Medical Sciences, Lorestan, Iran
*Corresponding author at: Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, 100 Poursina St., Keshavarz Blvd., Tehran, Iran.
Corresponding Author
Mohammad Emaneiniemaneini@tums.ac.ir
Received 24 January 2016, Revised 12 March 2017, Accepted 22 April 2017, Available Online 29 April 2017.
DOI
10.1016/j.jegh.2017.04.002How to use a DOI?
Keywords
Pseudomonas aeruginosa; Carbapenem-resistant; Carbapenemase; AmpC; oprD
Abstract

Carbapenems are the most important therapeutic options that effect against serious infections caused by multidrug resistant Pseudomonas aeruginosa (MDR-PA) isolates. Carbapenems resistant isolates of P. aeruginosa are increasing worldwide. The aim of this study was to determine the carbapenem resistance mechanisms in clinical P. aeruginosa isolates from burn patients, in Tehran, Iran. A total of 53 non-duplicated isolates of carbapenem-resistant P. aeruginosa were collected from burn patients. The presence of carbapenemase genes were determined by PCR. AmpC overproducer isolates were detected by phenotypic method. The mutation and transcription level of oprD were determined by PCR-sequencing and quantitative Real-time PCR (RT-PCR), respectively. Twenty-seven (50.9%) isolates were positive for carbapenemase (blaVIM = 25 and blaIMP = 2) and showed high-level resistance to imipenem and meropenem. Twenty-eight isolates were AmpC overproducers. All isolates had a mutation in the oprD gene and down-regulation of oprD was found in 56.6% of MDR-PA isolates. Although the presence of carbapenemase is the common mechanism of resistant to carbapenem, but carbapenem resistance was found by oprD mutation-driven and the AmpC overproducing isolates in Tehran, Iran.

Copyright
© 2017 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
Open Access
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Download article (PDF)
View full text (HTML)

Journal
Journal of Epidemiology and Global Health
Volume-Issue
7 - 3
Pages
155 - 159
Publication Date
2017/04/29
ISSN (Online)
2210-6014
ISSN (Print)
2210-6006
DOI
10.1016/j.jegh.2017.04.002How to use a DOI?
Copyright
© 2017 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
Open Access
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Cite this article

TY  - JOUR
AU  - Akbar Mirsalehian
AU  - Davood Kalantar-Neyestanaki
AU  - Morovat Taherikalani
AU  - Fereshteh Jabalameli
AU  - Mohammad Emaneini
PY  - 2017
DA  - 2017/04/29
TI  - Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran
JO  - Journal of Epidemiology and Global Health
SP  - 155
EP  - 159
VL  - 7
IS  - 3
SN  - 2210-6014
UR  - https://doi.org/10.1016/j.jegh.2017.04.002
DO  - 10.1016/j.jegh.2017.04.002
ID  - Mirsalehian2017
ER  -